glp-1/gip agonists GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica Emerging Role of Dual GLP-1
Description
Hiramatsu T, Ozeki A, Ishikawa H, Furuta S
Chen, J
Novo Nordisk : A market leader in GLP-1 receptor agonists with drugs like Ozempic and Rybelsus
Exceptionally, in a Phase 2a study of cotadutide, individual plasma amino acid profiles were reported
14 In contrast, GLP-1 RAs have primarily been associated with gastrointestinal side effects and have demonstrated more favorable psychiatric and cardiovascular safety profiles
Glaucoma: now and beyond
